Literature DB >> 17601434

Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.

Dan H Bourla1, David Sarraf, Steven D Schwartz.   

Abstract

PURPOSE: To describe the clinical, angiographic, and optical coherence tomography (OCT) features of high-dose tamoxifen retinopathy in three male patients.
DESIGN: Observational case series.
METHODS: A review of history, clinical examination, and findings on fluorescein angiography (FA) and optical coherence tomography (OCT) was conducted.
RESULTS: Three male patients receiving high-dose tamoxifen therapy sought treatment for vision loss and a crystalline maculopathy. Crystalline deposits were noted in the peripheral retina of two patients. All the patients showed macular leakage by FA, but cystoid macular edema (CME) on OCT was detected in two patients. Inner retinal hyperreflective deposits were identified by OCT in all the patients.
CONCLUSIONS: High-dose tamoxifen therapy may result in peripheral crystalline retinopathy in addition to perifoveal opacities. Angiographic evidence of macular edema may not unanimously correlate with presence of CME on OCT in these cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601434     DOI: 10.1016/j.ajo.2007.03.023

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiography.

Authors:  Yanling Ouyang; Pearse A Keane; Srinivas R Sadda; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-31       Impact factor: 4.799

Review 2.  Macular microhole and foveal red spot syndrome: a critical review of the literature.

Authors:  James H Garcia; Mark Johnson; Gaurav Shah; Carsten H Meyer; Gustavo B Melo; Eduardo B Rodrigues
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-02       Impact factor: 3.117

3.  Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.

Authors:  Xu Wang; Lian Zhao; Yikui Zhang; Wenxin Ma; Shaimar R Gonzalez; Jianguo Fan; Friedrich Kretschmer; Tudor C Badea; Hao-Hua Qian; Wai T Wong
Journal:  J Neurosci       Date:  2017-02-24       Impact factor: 6.167

4.  Estrogen antagonist and development of macular hole.

Authors:  Song Ee Chung; Seong Wook Kim; Hye Won Chung; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2010-10-05

Review 5.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

6.  Docetaxel Retinopathy: A Case Report.

Authors:  Sylvia Nghiem-Buffet; Salomon Yves Cohen; Audrey Giocanti-Auregan
Journal:  Case Rep Ophthalmol       Date:  2017-01-17

7.  Tamoxifen in horses: pharmacokinetics and safety study.

Authors:  Gonzalo Gajardo; Rodrigo López-Muñoz; Anita Plaza; Benjamin Uberti; José Sarmiento; Gabriel Morán; Claudio Henríquez
Journal:  Ir Vet J       Date:  2019-06-20       Impact factor: 2.146

Review 8.  Are we pharmacovigilant enough in ophthalmic practice?

Authors:  Ashok Dubey; Shailendra S Handu
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

9.  Concomitant use of tamoxifen and endoxifen in postmenopausal early breast cancer: prediction of plasma levels by physiologically-based pharmacokinetic modeling.

Authors:  Kristin Dickschen; Thomas Eissing; Thomas Mürdter; Matthias Schwab; Stefan Willmann; Georg Hempel
Journal:  Springerplus       Date:  2014-06-05

Review 10.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.